{"doi":"10.1093/noajnl/vdac130","title":"Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts","abstract":"Background: EGFR targeting antibody-drug conjugates (ADCs) are highly effective against EGFR-amplified tumors, but poor distribution across the blood-brain barrier (BBB) limits their efficacy in glioblastoma (GBM) when administered systemically. We studied whether convection-enhanced delivery (CED) can be used to safely infuse ADCs into orthotopic patient-derived xenograft (PDX) models of EGFRvIII mutant GBM. Methods: . CED was performed in nontumor and tumor-bearing mice. Immunostaining was used to evaluate ADC distribution, pharmacodynamic effects, and normal cell toxicity. Results: Dose-finding studies in orthotopic GBM6 identified single infusion of 2 μg Ser-T and 60 μg Depatux-M as safe and effective associated with extended survival prolongation (>300 days and 95 days, respectively). However, with serial infusions every 21 days, four Ser-T doses controlled tumor growth but was associated with lethal toxicity approximately 7 days after the final infusion. Limiting dosing to two infusions in GBM108 provided profound median survival extension of over 200 days. In contrast, four Depatux-M CED doses were well tolerated and significantly extended survival in both GBM6 (158 days) and GBM108 (310 days). In a toxicity analysis, Ser-T resulted in a profound loss in NeuN+ cells and markedly elevated GFAP staining, while Depatux-M was associated only with modest elevation in GFAP staining. Conclusion: CED of Depatux-M is well tolerated and results in extended survival in orthotopic GBM PDXs. In contrast, CED of Ser-T was associated with a much narrower therapeutic window.","journal":"Neuro-Oncology Advances","year":2022,"id":263428,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":13,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9559,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":521205,"name":"Michael S. Regan","orcid":"0000-0001-5252-2829","position":1,"is_corresponding":false},{"id":745745,"name":"Jessica I. Griffith","orcid":"0000-0003-1460-764X","position":2,"is_corresponding":false},{"id":920379,"name":"Sonia Jain","orcid":"0000-0002-3728-6642","position":3,"is_corresponding":false},{"id":711845,"name":"Sylwia A. Stopka","orcid":"0000-0003-3761-6899","position":4,"is_corresponding":false},{"id":571256,"name":"Danielle M. Burgenske","orcid":"0000-0003-0014-5579","position":5,"is_corresponding":false},{"id":571258,"name":"Katrina K. Bakken","orcid":"0009-0009-8900-0077","position":6,"is_corresponding":false},{"id":463936,"name":"Brett L. Carlson","orcid":"0000-0003-2460-3079","position":7,"is_corresponding":false},{"id":418165,"name":"Paul A. Decker","orcid":"0000-0002-3756-4227","position":8,"is_corresponding":false},{"id":920380,"name":"Rachael A. Vaubel","orcid":"0000-0001-8842-5975","position":9,"is_corresponding":false},{"id":424072,"name":"Sonja Dragojevic","orcid":"0000-0003-3971-8530","position":10,"is_corresponding":false},{"id":571257,"name":"Ann C. Mladek","orcid":"0000-0002-0508-6531","position":11,"is_corresponding":false},{"id":890573,"name":"Margaret A. Connors","orcid":"0000-0002-0094-0030","position":12,"is_corresponding":false},{"id":637635,"name":"Zeng Hu","orcid":null,"position":13,"is_corresponding":false},{"id":920381,"name":"Lihong He","orcid":"0000-0002-2024-7882","position":14,"is_corresponding":false},{"id":891106,"name":"Gaspar J. Kitange","orcid":null,"position":15,"is_corresponding":false},{"id":667994,"name":"Shiv K. Gupta","orcid":"0000-0002-9107-9935","position":16,"is_corresponding":false},{"id":920382,"name":"Thomas M. Feldsien","orcid":"0000-0003-0898-3606","position":17,"is_corresponding":false},{"id":920383,"name":"Didier R. Lefebvre","orcid":"0009-0002-4058-9916","position":18,"is_corresponding":false},{"id":521207,"name":"Nathalie Y.R. Agar","orcid":"0000-0003-3149-3146","position":19,"is_corresponding":false},{"id":414223,"name":"Jeanette E. Eckel‐Passow","orcid":"0000-0002-6113-1114","position":20,"is_corresponding":false},{"id":920384,"name":"Edward B. Reilly","orcid":"0000-0003-1999-7501","position":21,"is_corresponding":false},{"id":493801,"name":"William F. Elmquist","orcid":"0000-0002-7478-3429","position":22,"is_corresponding":false},{"id":32019,"name":"Jann N. Sarkaria","orcid":"0000-0001-7489-4885","position":23,"is_corresponding":false},{"id":920378,"name":"Kendra A. Porath","orcid":"0009-0009-0248-0523","position":0,"is_corresponding":true}],"reference_count":29,"raw_metadata":null,"created_at":"2026-07-19T00:26:33.413850Z","pmid":"36071925","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}